No ceiling stated: the Form D answers "Indefinite", so $290M sold is the running total of subscriptions, not a share of a target.
Facts
As its latest Form D states them
Fund type
Private Equity Fund
Adviser (attributed)
Medicxi Ventures Management (Jersey) Limited
State
—
Exemptions
Rule 506(b); Investment Company Act Section 3(c)(7)
First filed
2025-09-26
Latest filing
2025-09-26
First sale
2025-09-12
Filings
1 Form D
People
Named in Item 3 of its latest Form D, filed 2025-09-26
Related persons
Name
Relationship
Clarification
FRANCOIS H. CHESNAY
RelationshipDirector
ClarificationDIRECTOR OF THE MANAGING GENERAL PARTNER
LOUISA BLANCHET
RelationshipDirector
ClarificationDIRECTOR OF THE MANAGING GENERAL PARTNER
GIOVANNI PERICOLINI
RelationshipDirector
ClarificationDIRECTOR OF THE MANAGING GENERAL PARTNER
History
2025-09-26Form D filed · 021-558892-02
The other funds of Medicxi Ventures Management (Jersey) Limited (6 on Form ADV) and every Form D as filedSee plans
The firm and the filings behind Medicxi Co-Invest V LP
A fund's Form D states its target and what it has sold so far. The dashboard puts it beside the adviser's other funds from Form ADV, the startups linked to it, and every amendment as filed.
The adviser's Venture page: its Form ADV funds, assets and other Form D offerings
Where co-filings link it, the startups this fund backed
Every Form D and amendment as filed, with what each one stated
Everyone its filings name, linked to their other funds and companies
Part of the Venture plan — $140/mo at launch pricing ($350 list)